Showing results (81-90 of 8,862) with videos related to
Sort By:
Pageof 887
Journal of Translational Medicine|December 6, 2022
Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art reviewYue Li, Yuliang Jiang, Bin Qiu, et al.Journal of Translational Medicine|December 6, 2022
Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypesGe Zhang, Zaoqu Liu, Jinhai Deng, et al.Journal of Translational Medicine|December 6, 2022
Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosisTao Liu, Jing Gu, Yi Yuan, et al.Journal of Translational Medicine|June 28, 2022
Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasomeChao Wu, Yanqin Bian, Bingjie Lu, et al.Journal of Translational Medicine|June 30, 2022
Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphomaWei Yan, Xue Shi, Huihan Wang, et al.Journal of Translational Medicine|June 11, 2022
Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic populationGuotai Sheng, Maobin Kuang, Ruijuan Yang, et al.Journal of Translational Medicine|June 25, 2022
A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3XYuliang Pan, Yuxing Zhu, Jun Zhang, et al.Journal of Translational Medicine|June 25, 2022
An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinomaYingzhen Gao, Liuyi Shen, Tianyue Dong, et al.Journal of Translational Medicine|May 5, 2022
Comparison of immune cells and diagnostic markers between spondyloarthritis and rheumatoid arthritis by bioinformatics analysisJiaqian Wang, Yuan Xue, Liang ZhouJournal of Translational Medicine|May 5, 2022
TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5Xiaoying Jin, Dandan Wang, Mengxia Lei, et al.Pageof 887